Provider margin should be reviewed before it becomes emotional
Many medspas only talk about provider economics when something already feels wrong: a commission conversation is tense, product cost looks high, or revenue is strong but cash still feels thin. By then, the discussion is usually personal instead of operational.
A provider margin cadence creates a neutral rhythm. The practice reviews revenue, product usage, COGS, discounts, waste, comps, corrections, and service mix before the numbers become a surprise. The point is not to shame a provider. The point is to understand what is driving profit.
Separate weekly signal from monthly review
A weekly review should be short and operational. Look for obvious variance: unusually high product usage, heavy discounting, frequent touch-ups, missed waste logging, or a provider running out of a product faster than expected.
The monthly review should be more complete. Compare provider gross margin, service mix, average product cost per visit, discount impact, correction volume, and inventory variance. Weekly signal catches issues early; monthly review shows whether the pattern is real.
Use actual COGS, not standard product assumptions
Provider margin cannot be trusted if the practice uses a generic product cost estimate. A filler syringe, neurotoxin vial, GLP-1 lot, peptide vial, or retail item can have different unit cost depending on the purchase date, vendor terms, lot, and waste pattern.
The cleanest review uses the product and lot actually used in the visit. That lets the operator distinguish clinical variation from cost variation, supplier changes, discounting, and shrinkage.
Review service mix before judging the provider
A provider with lower gross margin may be carrying more product-intensive services, more starter visits, more discounted packages, or more complex correction work. A provider with higher revenue may still have weak contribution if the mix is expensive to deliver.
Service mix context keeps the review fair. Compare Botox, filler, biostimulator, GLP-1, IV therapy, retail, membership, and package redemptions separately before rolling everything into one provider score.
Turn margin variance into decisions
A useful provider margin review ends with a decision. If margin is weak because discounting is too frequent, the fix may be pricing policy. If product usage is high, the fix may be protocol review or training. If corrections are driving cost, the fix may be consult workflow or documentation.
If variance comes from lot cost or supplier increases, the fix is not provider coaching at all. It may be reorder timing, package repricing, membership math, or supplier negotiation. Margin data is only useful when it points to the right lever.
Keep compensation conversations grounded but separate
Otzaro is not payroll software, and provider compensation needs legal, employment, and business judgment. But commission and bonus conversations are stronger when the practice can see revenue beside product cost and gross margin.
The cadence should create shared operating truth before payout decisions happen. Owners can see where profit is coming from, providers can understand how product usage affects economics, and the practice can improve without relying on hunches.
A provider margin review cadence should include
Weekly signal checks for product usage variance, discounts, waste, corrections, and stock movement.
Monthly provider margin review by revenue, visit-level COGS, service mix, gross profit, and margin percentage.
Lot-level cost context so supplier changes and product cost shifts are not mistaken for provider behavior.
Clear follow-up actions tied to pricing, protocol training, package economics, inventory control, or compensation context.
FAQ
How often should a medspa review provider profitability?
Most medspas should run a light weekly signal review and a deeper monthly provider margin review. Weekly review catches unusual usage, discounting, waste, and corrections early. Monthly review confirms broader patterns by service mix, COGS, gross profit, and margin.
What should be included in a provider margin review?
A provider margin review should include provider revenue, actual product usage by visit, lot-level COGS, discount impact, waste, comps, corrections, service mix, gross profit, and margin percentage.
Is provider margin the same as provider production?
No. Provider production is revenue. Provider margin is revenue after direct product costs and related adjustments. In a product-heavy medspa, those numbers can tell very different stories.